Fda

“Among the violations was the discovery of suspected counterfeit anti-rabies vaccines identified as 'Equirab,' bearing batch numbers flagged under FDA Advisory No.

Edit

The FDA’s refusal to review Moderna’s application to sell a new flu shot is part ...

Wall Street Journal 12 Feb 2026

The head of the agency’s vaccine division, Vinay Prasad, has overruled pushback from career staffers ... .

Edit

FDA flags illegal anti-rabies vaccines in Aurora

Manila Standard 12 Feb 2026

The Food and Drug ...

Edit

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or ...

Hastings Tribune 12 Feb 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Feb 11, 2026-- ... .

Edit

Pastured Poultry Producers Urge FDA to Align "Pasture-Raised" Egg Labeling with USDA Standards

Brattleboro Reformer 12 Feb 2026

Food and Drug Administration (FDA) to clarify how ...

Edit

U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer (Zai Lab Ltd)

Public Technologies 12 Feb 2026

) PDF Version Optune Pax concomitant with gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced ...

Edit

Novel Anti-Fibrotic Drug AK3280 Cleared by FDA to Initiate Phase 2 Proof-of-Concept Clinical Trial in IPF

PR Newswire 12 Feb 2026

Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AK3280, a novel anti-fibrotic therapy for the treatment of idiopathic pulmonary fibrosis (IPF).

Edit

U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer (Novocure Ltd)

Public Technologies 12 Feb 2026

Optune Pax concomitant with gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer ... Data Supporting the Optune Pax FDA Approval.

Edit

Moderna says FDA refuses its application for new mRNA flu vaccine

The News-Gazette 11 Feb 2026

The FDA's decision reflects heightened scrutiny under ...

Edit

The FDA has refused to review Moderna’s application to sell a new flu shot, the ...

Wall Street Journal 11 Feb 2026

The company said the agency wouldn’t review its application on the grounds that the study testing the shot wasn’t sufficient ... .

Edit

FDA declines to review Moderna application for new flu vaccine

The Guardian 11 Feb 2026

US regulators will not review Moderna’s request to license a new, potentially more effective flu shot – even though the ...

Podcasts:

Latest News for: fda

Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar

U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

FDA finds vaccine violations linked to child’s rabies death in Aurora

The FDA’s refusal to review Moderna’s application to sell a new flu shot is part ...

FDA flags illegal anti-rabies vaccines in Aurora

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or ...

Pastured Poultry Producers Urge FDA to Align "Pasture-Raised" Egg Labeling with USDA Standards

U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer (Zai Lab Ltd)

Novel Anti-Fibrotic Drug AK3280 Cleared by FDA to Initiate Phase 2 Proof-of-Concept Clinical Trial in IPF

U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer (Novocure Ltd)

Moderna says FDA refuses its application for new mRNA flu vaccine

The FDA has refused to review Moderna’s application to sell a new flu shot, the ...

FDA declines to review Moderna application for new flu vaccine

Article Search

EXPLORE WN.com